Low uptake of cascade germline testing in cancer a ‘public health emergency’

Patients with cancer who have germline mutations overwhelmingly acknowledge the importance of informing relatives of their risks, but gaps in testing show the health care system has not adequately supported that mission.A survey of nearly 2,000 patients with genetic variants predisposing them to cancer showed almost 90% viewed sharing results as their responsibility and notified their